Brenipatide is a new incretin-based peptide in development by Eli Lilly and Company. It works on the same general pathways as tirzepatide and retatrutide, targeting GIP and GLP-1 receptors. That part isn’t exciting. What’s different is what they’re trying to use it for. This isn’t just being looked at for fat loss or blood sugar. It’s being studied for things like alcohol cravings, smoking relapse, and even opioid-related behavior. That should tell you right away this isn’t just about eating less. This is about how the brain handles reward. Most people think GLP-1 equals appetite suppression. That’s surface level. The deeper layer is that these pathways interact with dopamine and reward signaling. That’s why some people on these compounds lose interest in food, alcohol, even certain habits. Brenipatide is being pushed further into that lane. So instead of thinking “this helps you eat less,” think “this might help you want less.” That’s a completely different conversation. Now here’s the reality. This is still in research. No real protocols, no long-term outcome data, and no clear idea yet where it will land compared to something like tirzepatide or retatrutide. So this isn’t something you should be chasing. But it is something to watch. Because if it does what they’re hoping, this class of peptides stops being just about fat loss and starts becoming about controlling cravings, habits, and behaviors at a much deeper level. That’s where things get interesting.

What is the best cycle for: Wolverine? Reta? Ghk Cu?

What’s actually holding your legs back right now Be honest Is it lack of structure Knee or low back discomfort Skipping leg day Not pushing hard enough Or just not knowing what works Drop one answer below Second question Did you train legs this week yet Yes or no If yes What did you do If no When are you doing it

https://open.spotify.com/episode/4fbwbg8OPsHvSxkaPELB2P?si=vV5udVkJTY6BZLPBAg4yPg

This will he the thread for the order #s